The abstract is read at the publisher; the summary is JClub's.
YEATS2 is markedly elevated in hepatocellular carcinoma and is linked to unfavorable clinical features and decreased survival, while promoting HCC cell proliferation, migration, and invasion.
- Why it matters: The role of YEATS2 in hepatocellular carcinoma progression and metastasis is not fully defined, limiting mechanistic understanding and therapeutic targeting.
- What they did: Using in vitro and in vivo functional assays plus RNA sequencing, mass spectrometry, chromatin immunoprecipitation, and co-immunoprecipitation, the study shows YEATS2 activates TAZ/AKT signaling and aerobic glycolysis via upregulating TGFBR2. It also finds matrix stiffness induces YEATS2 by increasing HIF-1α binding to the YEATS2 promoter.
- The result: The YEATS2–TGFBR2–TAZ–AKT axis connects matrix stiffness to metabolic reprogramming and HCC progression, supporting YEATS2 as a potential therapeutic target for HCC.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.